Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Cetyl Myristoleate (CMO) | Omega-3 (EPA/DHA) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | — | 2-4g combined EPA/DHA daily (targeting 2:1 EPA:DHA ratio for inflammation; 1:1 for cognitive) |
| Timing | — | With meals containing fat for absorption. Split dose AM/PM. |
| Cycle Duration | — | ongoing |
| Evidence Level | Limited-Moderate | strong_human |
Fatty acid ester with anti-inflammatory and joint-lubricating properties. Modulates immune response by inhibiting 5-lipoxygenase and modulating prostaglandin synthesis. Reduces joint inflammation and improves range of motion in arthritic conditions.
EPA and DHA incorporate into cell membrane phospholipids, modulating membrane fluidity and lipid raft signaling. EPA competitively inhibits arachidonic acid conversion via COX-2 and 5-LOX, reducing pro-inflammatory eicosanoids (PGE2, LTB4) while generating anti-inflammatory resolvins and protectins. DHA is critical for neuronal membrane integrity, modulating BDNF expression and synaptic plasticity via Nrf2 and NF-kB pathways.
2-4g combined EPA/DHA daily (targeting 2:1 EPA:DHA ratio for inflammation; 1:1 for cognitive)
With meals containing fat for absorption. Split dose AM/PM.
ongoing
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →